Kimberly Buchanan

Kimberly Buchanan is currently working at Ossium Health as a Supervisor in Development and Lab Management. Prior to this role, Kimberly worked at Mallinckrodt Pharmaceuticals where Kimberly played a key role in supporting the late-stage development and commercialization of the StrataGraft® skin graft, which received FDA approval in 2021. Kimberly also has a strong academic background in Biomedical Engineering, holding a Master's and Bachelor's degree from the University of Wisconsin-Madison. Kimberly's experience includes roles as a Graduate Research Assistant, Graduate Teaching Assistant, and Undergraduate Research Assistant within the field. Additionally, Kimberly has practical experience as a Clinical Intern at NeuroSensory Centers of America.